Nat. Rev. Nephrol. doi: /nrneph

Slides:



Advertisements
Similar presentations
From: Diabetic Retinopathy: Battling the Global Epidemic
Advertisements

Immune mediators of tissue remodelling and lung function impairment in tuberculosis. Immune mediators of tissue remodelling and lung function impairment.
Figure 6 Cholesterol metabolism in obesity-related glomerulopathy
Intermyocellular fat depot
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Figure 6 Effects of adiponectin on podocyte function
Figure 4 Expression of coagulation protease receptors in renal cells
Figure 3 Angiotensin signalling in adiporenal crosstalk
Figure 4 Interactions between adipose, the microbiome and kidney
Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 3 Extracellular stimuli to HSC activation
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Pathological features of lupus nephritis subtypes
Figure 3 The contribution of the tumour microenvironment
Figure 3 The fat–intestine–kidney axis
Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)
Figure 7 The efficacy of phosphate-binder therapy
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)
Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy.
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
NAFLD, Obesity, and Bariatric Surgery
Figure 1 Currently recognized factors that influence the development of scleroderma renal crisis Figure 1 | Currently recognized factors that influence.
Figure 1 The central role of chronic prostate
Figure 4 Model of changes in the serum levels
Figure 4 Effects of glucagon-like peptide 1 (GLP-1) and
Figure 2 Roles of mTOR complexes in the kidney
Mechanisms of Obesity-Induced Gastrointestinal Neoplasia
Nat. Rev. Nephrol. doi: /nrneph
Figure 5 Potential roles of phosphate and fibroblast growth factor 23 (FGF-23) in the development of cardiovascular disease in patients with chronic kidney.
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Organ crosstalk in the pathophysiology
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Glomerular injury in lupus nephritis
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer  Roy M. Bremnes,
Figure 3 Loss of the glycocalyx leads to podocyte and kidney injury
Figure 2 BMPs in brown and beige adipogenesis and function
Figure 1 Distinct features of adipocytes
Figure 5 Role of VEGF in stroke
Figure 4 Podocyte–endothelial cross talk and activation of heparanase
Figure 1 Involvement of pVHL in cellular physiology and RCC
Figure 4 Mechanisms of leptin function on kidney injury
Figure 1 Heart–brain–kidney interactions control cardiac remodelling
Pro-endometriotic niche in endometriosis
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Regulation of TGF-β1/Smad signalling by microRNAs (miRs) in tissue fibrosis Figure 3 | Regulation of TGF-β1/Smad signalling by microRNAs (miRs)
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions  Batya B. Davidovici, Naveed Sattar,
Nat. Rev. Nephrol. doi: /nrneph
Volume 21, Issue 4, Pages (April 2013)
Hypoxia: Signaling the Metastatic Cascade
Figure 2 Mechanisms of crosstalk between adipocytes and the kidney
The renin–angiotensin–aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?  Sharon J. Nessim, Jeffrey.
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Process and mechanisms of blood vessel formation.
Osteopontin in diabetic nephropathy: signpost or road?
Macrophages and hypoxia in human chronic kidney disease
Pathogenesis of idiopathic pulmonary fibrosis (IPF).
Figure 2 Haemodynamic alterations in obesity
Jair Bar, MD, PhD, Glenwood D. Goss, MD, FCPSA, FRCPC 
Figure 2 Initiators of obesity-associated inflammation in adipocytes
The VEGF Family, the Inside Story
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
Figure 3 Underlying mechanisms of TREG cells in atherosclerosis
Post-ischemic vascular repair mechanisms and the growth factors involved. Post-ischemic vascular repair mechanisms and the growth factors involved. The.
Molecular pathways underlying angiogenesis.
Can we cure HIV-1-associated nephropathy in transgenic mice?
Volume 76, Issue 2, Pages (July 2009)
Presentation transcript:

Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.75 Figure 3 Potential role of adipokines in the development of obesity-related glomerulopathy Figure 3 | Potential role of adipokines in the development of obesity-related glomerulopathy. In obesity, satiated fat cells facilitate adipose tissue expansion by secreting angiogenic and inflammatory adipokines such as angiopoietins, vascular endothelial growth factor (VEGF), and cathepsins. These adipokines promote stromal rearrangements, neovascularization and the formation of novel adipocytes from pericytes of the microvasculature. Angiogenesis and adipogenesis are intricately linked, and disturbed angiogenesis has been associated with diminished adipose tissue expandability. Systemically circulating adipokines might reach the kidney and have local effects on mesangial cells, podocytes, and tubular cells, promoting maladaptive responses to glomerular hyperfiltration and albuminuria. Ang II, angiotensin II, HIF-1, hypoxia-inducible factor-1; MCP-1, monocyte chemoattractant protein-1 (also known as C-C motif chemokine 2); MMP, matrix metalloproteinase; NEFA, non-esterified fatty acid; TGF-β, transforming growth factor β. D’Agati, V. D. et al. (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.75